Novita Health

Novita HealthNovita Health

Novita Health

Stealth modeStealth Mode

Novita Health provides online access to weight loss medications and personalized health support through physician consultations and nutrition guidance.

DR 0Speed 552026ActiveKennewick, United States
Rate

About

Novita Health is a digital health platform offering personalized weight loss programs. They connect patients with board-certified physicians for consultations and ongoing support, including access to GLP-1 receptor agonists like Semaglutide and Tirzepatide, and nutritionists. The service aims to provide convenient and effective solutions for managing weight and improving overall health.
Frequently asked

What does Novita Health do?

Novita Health is a digital health platform offering personalized weight loss programs. They connect patients with board-certified physicians for consultations and ongoing support, including access to GLP-1 receptor agonists like Semaglutide and Tirzepatide, and nutritionists. The service aims to provide convenient and effective solutions for managing weight and improving overall health.

What is Novita Health's Effective Domain Rating?

StartupHub's Effective Domain Rating for Novita Health is 36 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 0, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.

Is Novita Health trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Novita Health is 52 out of 100, based on site security posture and privacy practices.

Where is Novita Health headquartered?

Novita Health is headquartered in Kennewick, United States.

When was Novita Health founded?

Novita Health was founded in 2026.

What industry does Novita Health operate in?

Novita Health operates in HealthTech, Telemedicine, Weight Loss, Medication Management, Nutrition, Chronic Disease Management.

Comments

No comments yet. Be the first to share your take.